These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22134589)

  • 1. An increase in intraocular pressure after intravitreal steroid injection facilitates reduction of macular edema.
    Chae JB; Joe SG; Yang SJ; Lee JY; Kim JG; Yoon YH
    Eye (Lond); 2012 Mar; 26(3):479-80. PubMed ID: 22134589
    [No Abstract]   [Full Text] [Related]  

  • 2. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion.
    Batioglu F; Ozmert E; Akmese E
    Ann Ophthalmol (Skokie); 2007; 39(4):307-12. PubMed ID: 18025651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Intravitreal Preservative-Free Triamcinolone Acetonide (Triesence) for Macular Edema.
    Chang AA; Li H; Broadhead GK; Luo K; Zhu M
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):563-9. PubMed ID: 26218262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
    Bae JH; Lee CS; Lee SC
    Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.
    Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
    Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G
    Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
    Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I
    Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
    Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
    J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal triamcinolone.
    Spaide RF
    Ophthalmology; 2008 Aug; 115(8):1436; author reply 1436-7. PubMed ID: 18675704
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema.
    Habot-Wilner Z; Sallam A; Pacheco PA; Do HH; McCluskey P; Lightman S
    Eur J Ophthalmol; 2011; 21 Suppl 6():S56-61. PubMed ID: 23264330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
    Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O
    Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
    Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective laser trabeculoplasty for the treatment of intraocular pressure elevation after intravitreal triamcinolone injection.
    Baser E; Seymenoglu R
    Can J Ophthalmol; 2009 Jun; 44(3):e21. PubMed ID: 19506591
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of visual acuity and intraocular pressure in the treatment of macular diabetic edema with intravitreous triamcinolone].
    Rezende MP; Dias AF; Oshima A; Andrade EP; Serracarbassa PD
    Arq Bras Oftalmol; 2010; 73(2):129-34. PubMed ID: 20549040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone acetonide and secondary ocular hypertension.
    Jonas J; Heatley G; Spaide R; Varma R
    J Glaucoma; 2005 Apr; 14(2):168-71. PubMed ID: 15741821
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial.
    Audren F; Erginay A; Haouchine B; Benosman R; Conrath J; Bergmann JF; Gaudric A; Massin P
    Acta Ophthalmol Scand; 2006 Oct; 84(5):624-30. PubMed ID: 16965492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.